3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Completed
16
Recruiting
2
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Prostatic Neoplasms
25
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma
15
Burkitt Lymphoma
11
Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Follicular
7
Lymphoma, B-Cell
7
Hodgkin Disease
6
Lymphoma, Non-Hodgkin
5
Recurrence
3
Prostatic Neoplasms, Castration-Resistant
3
Leukemia
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Melanoma
2
Lymphoproliferative Disorders
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, AIDS-Related
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Immunoblastic Lymphadenopathy
2
Vasculitis, Central Nervous System
1
Urogenital Neoplasms
1
Stiff-Person Syndrome
1
Stage II Prostate Adenocarcinoma
1
Skin Neoplasms
1
Rasmussen subacute encephalitis
1
Prostate Cancer, Hereditary, 7
1
Interventions
venetoclax
26
ibrutinib
23
Rituximab
22
Cyclophosphamide
21
obinutuzumab
18
acalabrutinib
18
fludarabine phosphate
13
fludarabine
13
zanubrutinib
8
Bendamustine Hydrochloride
8
pirtobrutinib
7
Biopsy
7
Specimen Handling
6
Lenalidomide
6
CT-P10
6
Whole-Body Irradiation
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
duvelisib
3
Melphalan
3
Chlorambucil
3
Busulfan
3
idelalisib
2
daratumumab
2
Vincristine
2
Prednisone
2
Patient Reported Outcome Measures
2
Observation
2
Mesna
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Prednisone
×
Clear all
NCT04542824
2026-06-02
EPCOREâ„¢ NHL-3
Genmab
Phase 1/2
Active not recruiting
78 enrolled
NCT04623541
2026-06-02
EPCOREâ„¢ CLL-1
Genmab
Phase 1/2
Active not recruiting
194 enrolled